Business / Finance

RSS

Seward increases production capacity for Stomacher blender bags in the UK

Seward Ltd., manufacturer of the world leading range of original Stomacher paddle blenders and accessories used in sample preparation for microbiological analysis, has increased production capacity for Stomacher blender bags with additional manufacturing in the UK.

4 Apr 2014

United Recovery Systems acquires Array Services Group

United Recovery Systems, a portfolio company of Audax Private Equity, announced it has completed the acquisition of Array Services Group. Array, headquartered in Sartell, MN, is a leading regionally-focused provider of revenue cycle management, receivables management, and call center services to hospitals, healthcare systems, retail businesses, and financial service institutions.

4 Apr 2014

ZirMed acquires TransEngen's payment processing and patient engagement solutions

ZirMed, a leading health information connectivity and management solutions company, today announced that it has acquired the payment processing, patient eligibility and patient estimation business solutions owned by TransEngen Inc., a company located in Shelton, CT.

4 Apr 2014

Aesynt completes acquisition of Health Robotics

Aesynt™, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, announced it has completed the acquisition of Health Robotics, the leading global supplier of automated technology for intravenous (IV) medication preparation, compounding and dispensing.

3 Apr 2014

CTMM, TI Pharma team up to create new public-private healthcare innovation

Leading Dutch technology institutes CTMM (Center for Translational Molecular Medicine) and TI Pharma have joined forces, in a merger that addresses the growing interdependence of medicines and medical technology.

3 Apr 2014

Accele Venture Partners co-led $4.1M Series A private equity financing of Otologic Pharmaceutics

Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc., announced today that it has co-led a $4.1 million Series A private equity financing of Otologic Pharmaceutics, Inc. (OPI), a development-stage biopharmaceutical company committed to developing and commercializing novel pharmacological solutions and approaches to treat hearing disorders.

3 Apr 2014

Corium International prices initial public offering of common stock

Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today the pricing of its initial public offering of 6,500,000 shares of common stock at a price to the public of $8.00 per share.

3 Apr 2014

Walgreens' March sales up 4.5% to $6.43 billion

Walgreens had March sales of $6.43 billion, an increase of 4.5 percent from $6.16 billion for the same month in fiscal 2013.

3 Apr 2014

Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

Neurovance, Inc. today announced that it has closed a $6.3 million extension to its series A1 financing round to further advance development of EB-1020 SR, a non-stimulant, for the treatment of all subtypes of adult ADHD (attention deficit hyperactivity disorder).

3 Apr 2014

Foundation Medicine, Clovis Oncology expand collaboration to develop novel companion diagnostic test

Foundation Medicine, Inc. and Clovis Oncology, Inc. today announced the expansion of their ongoing collaboration to incorporate a coordinated regulatory strategy for the development of a novel Premarket Approval (PMA) companion diagnostic test.

3 Apr 2014

Crescendo raises additional £2M ($3.3M) in final close of Series A financing from EMBL Ventures

Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.

3 Apr 2014

Biomet's consolidated net sales increase 6.6% to $822.5 million

Biomet, Inc. announced today financial results for its third quarter ended February 28, 2014.

3 Apr 2014

Affygility’s occupational exposure limit monograph is now available for delta-9-tetrahydrocannabinol

Affygility Solutions is pleased to announce that its occupational exposure limit monograph is now available for delta-9-tetrahydrocannabinol, the principal psychoactive ingredient in marijuana.

3 Apr 2014

Cardinal Health agrees to acquire AccessClosure for $320 million

Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014.

3 Apr 2014

Actavis opens new regional headquarters in Singapore

Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced the official opening of its new regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region.

3 Apr 2014

GE Healthcare agrees to acquire CHCA Computer Systems

GE Healthcare announced today it has agreed to acquire CHCA Computer Systems Inc., an operating room (OR) management and analytics solutions provider, headquartered in Montreal, Canada. CHCA develops the Opera software application, which has helped increase productivity and patient satisfaction in the OR by providing real-time data to support the decision making and management of surgical procedures.

2 Apr 2014

EnVivo Pharmaceuticals changes its name to FORUM Pharmaceuticals

EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better reflects the company's strong position as a late-stage, purpose-built organization that is focused on conquering challenging brain diseases such as schizophrenia and Alzheimer's disease.

2 Apr 2014

Medworxx announces partnership with Leidos Health

Medworxx Solutions Inc. today announced a partnership with Leidos Health (formerly part of SAIC and includes the businesses of former maxIT Healthcare and Vitalize Consulting Solutions) which formalizes their agreement to leverage each organization's global expertise in patient flow optimization.

2 Apr 2014

Stratasys signs definitive agreements to acquire Solid Concepts and Harvest Technologies

Stratasys Ltd., a leading global provider of 3D printing and additive manufacturing solutions, today announced that it has entered into definitive agreements to acquire two privately-held companies, Solid Concepts Inc. and Harvest Technologies.

2 Apr 2014

ABL enters into licensing agreement with CRP-Santé for COMET software

Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.

2 Apr 2014